SynthesisCancer medicine2020

Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review.

Adam S Komorowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.